Form D · Hedge Fund

Wellington Biotechnology Long/Short Fund, L.P.

Boston, MA · CIK 0001163425

Offering snapshot reported Apr 17, 2026 · SEC filing

Reported sold
$484M
Indefinite offering
Investors reported
164
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Nov 1, 2001
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$242M$484MMar 16, 2009: $165,358,860.00Mar 16, 2009Mar 16, 2010: $227,747,262.00Mar 17, 2011: $228,547,652.00Mar 15, 2012: $228,647,652.00Mar 4, 2013: $232,542,025.00Mar 4, 2014: $237,603,132.00Jan 23, 2015: $247,030,594.00Jan 22, 2016: $254,849,427.00Jul 14, 2016: $259,591,939.00Jul 14, 2017: $272,279,225.00Jan 23, 2018: $378,969,923.00Jan 23, 2019: $430,481,440.00Jan 23, 2020: $434,162,183.00Feb 25, 2020: $433,756,183.00Feb 25, 2021: $436,184,742.00Feb 25, 2022: $438,638,559.00Feb 23, 2023: $440,742,559.00Feb 23, 2024: $457,181,493.00Apr 17, 2024: $469,361,559.00Apr 17, 2025: $471,718,436.00Apr 17, 2026: $483,859,908.00Apr 17, 2026

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$471,718,436 → $483,859,908
  • Reported investors163 → 164

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 17, 2026Amendment$483,859,908$12,141,472vs Apr 17, 2025164SEC filing
Apr 17, 2025Amendment$471,718,436$2,356,877vs Apr 17, 2024163SEC filing
Apr 17, 2024Amendment$469,361,559$12,180,066vs Feb 23, 2024162SEC filing
Feb 23, 2024Amendment$457,181,493$16,438,934vs Feb 23, 2023162SEC filing
Feb 23, 2023Amendment$440,742,559$2,104,000vs Feb 25, 2022161SEC filing
Feb 25, 2022Amendment$438,638,559$2,453,817vs Feb 25, 2021159SEC filing
Feb 25, 2021Amendment$436,184,742$2,428,559vs Feb 25, 2020158SEC filing
Feb 25, 2020Amendment$433,756,183-$406,000vs Jan 23, 2020157SEC filing
Jan 23, 2020Amendment$434,162,183$3,680,743vs Jan 23, 2019158SEC filing
Jan 23, 2019Amendment$430,481,440$51,511,517vs Jan 23, 2018158SEC filing
Jan 23, 2018Amendment$378,969,923$106,690,698vs Jul 14, 2017114SEC filing
Jul 14, 2017Amendment$272,279,225$12,687,286vs Jul 14, 2016109SEC filing
Jul 14, 2016Amendment$259,591,939$4,742,512vs Jan 22, 2016103SEC filing
Jan 22, 2016Amendment$254,849,427$7,818,833vs Jan 23, 2015100SEC filing
Jan 23, 2015Amendment$247,030,594$9,427,462vs Mar 4, 201496SEC filing
Mar 4, 2014Amendment$237,603,132$5,061,107vs Mar 4, 201391SEC filing
Mar 4, 2013Amendment$232,542,025$3,894,373vs Mar 15, 201288SEC filing
Mar 15, 2012Amendment$228,647,652$100,000vs Mar 17, 201184SEC filing
Mar 17, 2011Amendment$228,547,652$800,390vs Mar 16, 201084SEC filing
Mar 16, 2010Amendment$227,747,262$62,388,402vs Mar 16, 200984SEC filing
Mar 16, 2009Amendment$165,358,860No comparisonNot reportedSEC filing

Offering details

Securities
Equity, Pooled investment fund
Exemptions
06b, 3C, 3C.7
Duration over one year
Yes
Business combination
No
Sales commissions
$228K (estimated)
Finders' fees
$0 (estimated)
Form D file number
021-39484
If applicable, employees of the recipient listed in item 12, are paid an amount equal to a percentage of the management fee paid to the Investment Manager (or its affiliate) attributable to certain assets under management.

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Wellington Funds Distributors Inc.000152768
Citigroup Global Markets Inc.000007059
Citi Private Advisory, LLC000153777

Source: Form D, filed Apr 17, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

WELLINGTON BIOTECHNOLOGY LONG/SHORT FUND, L.P.

Investment adviser: WELLINGTON ALTERNATIVE INVESTMENTS LLC

Gross asset value
$177M
Beneficial owners
29
ADV minimum commitment
$2M

Reported in Form ADV on Sep 29, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator INTERNATIONAL FUND SERVICES (N.A.), L.L.C. NEW YORK, New York, United States Investor statements: Yes (provided to all investors) Related to adviser: No
Auditor PRICEWATERHOUSECOOPERS LLP BOSTON, Massachusetts, United States
Custodian BOFA SECURITIES, INC. NEW YORK, New York, United States Related to adviser: No
Custodian GOLDMAN SACHS & CO. LLC NEW YORK, New York, United States Related to adviser: No
Custodian J.P. MORGAN SECURITIES LLC NEW YORK, New York, United States Related to adviser: No
Custodian MORGAN STANLEY & CO. LLC NEW YORK, New York, United States Related to adviser: No
Custodian STATE STREET BANK AND TRUST COMPANY BOSTON, Massachusetts, United States Related to adviser: No
Marketer ICAPITAL GLOBAL ALTERNATIVES, LLC NEW YORK, New York, United States Related to adviser: No
Marketer WELLINGTON FUNDS DISTRIBUTORS INC. BOSTON, Massachusetts, United States Related to adviser: Yes
Prime broker BOFA SECURITIES, INC. NEW YORK, New York, United States
Prime broker GOLDMAN SACHS & CO. LLC NEW YORK, New York, United States
Prime broker J.P. MORGAN SECURITIES LLC NEW YORK, New York, United States
Prime broker MORGAN STANLEY & CO. LLC NEW YORK, New York, United States
Provider details
Annual audit
Yes
Prime brokers
Yes
Custodians
Yes
Administrator other than the adviser
Yes
External marketing
Yes

PRICEWATERHOUSECOOPERS LLP
PCAOB 238

BOFA SECURITIES, INC.
SEC 8-69787

GOLDMAN SACHS & CO. LLC
SEC 8-129

J.P. MORGAN SECURITIES LLC
SEC 8-35008

MORGAN STANLEY & CO. LLC
SEC 8-15869

STATE STREET BANK AND TRUST COMPANY
LEI 571474TGEMMWANRLN572

ICAPITAL GLOBAL ALTERNATIVES, LLC
CRD 324457

WELLINGTON FUNDS DISTRIBUTORS INC.
CRD 152768 · SEC 8-68476

BOFA SECURITIES, INC.
CRD 283942 · SEC 8-69787

GOLDMAN SACHS & CO. LLC
CRD 361 · SEC 8-129

J.P. MORGAN SECURITIES LLC
CRD 79 · SEC 8-35008

MORGAN STANLEY & CO. LLC
CRD 8209 · SEC 8-15869

Filing source

Form ADV 2130971 · Sep 29, 2026 · Schedule D 7.B.(1), fund 805-8429466434

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
John E. Bruno Director
Christopher G. Kirk Director
Gregory S. Konzal Executive
Neil A. Medugno Director
Susan G. O'connell Director
Philip H. Perelmuter Director
Sara Lou Sherman Executive
Edward Steinborn Director
Brendan J. Swords Director
Perry M. Traquina Director
Wellington Alternative Investments Llc Executive
Wellington Hedge Management Llc Executive
Wellington Management Company Llp Executive
Wellington Management Investment, Inc. Executive

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:
Wellington Alternative Investments Llc 280 Congress St
Boston, MA, 02210